default author photo

Zulvikar Syambani Ulhaq

Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang

Jl. Gajayana No.50

Malang, East Java

SCHOLARLY PAPERS

7

DOWNLOADS

176

TOTAL CITATIONS

1

Scholarly Papers (7)

1.

Estrogen and the Disease Severity of SARS-CoV-2 Infection

Number of pages: 7 Posted: 22 May 2020
Zulvikar Syambani Ulhaq and Gita Vita Soraya
Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang and Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar
Downloads 117 (608,822)
Citation 1

Abstract:

Loading...

SARS-CoV-2, COVID-19, estrogen, estrogen receptor, inflammatory mediator, sexual dysmorphism

2.

LINGO2 and Movement Disorder Predisposition: Results of a Meta-Analysis

Number of pages: 8 Posted: 16 Nov 2020
Gita Vita Soraya, Zulvikar Syambani Ulhaq and Cristian Peinado Garcia
Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang and Department of General Surgery, Weston General Hospital
Downloads 59 (970,490)

Abstract:

Loading...

LINGO2, Parkinson's Disease, Essential T, Essential Tremor

3.

Anti-IL-6 Receptor Antibody Treatment for Severe COVID-19 and the Potential Implication of IL-6 Gene Polymorphisms in Novel Coronavirus Pneumonia

Medicina Clinica DOI: 10.1016/j.medcli.2020.07.002
Posted: 11 May 2020 Last Revised: 20 Oct 2020
Zulvikar Syambani Ulhaq and Gita Vita Soraya
Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang and Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar

Abstract:

Loading...

anti-IL-6 receptor antibody, CRP, COVID-19, therapy, IL-6, polymorphism, pneumonia

4.

Recurrent Positive SARS-CoV-2 RNA Tests in Recovered and Discharged Patients

Available at Revista Clínica Española (English Edition) https://doi.org/10.1016/j.rceng.2020.06.005
Posted: 11 May 2020 Last Revised: 20 Oct 2020
Zulvikar Syambani Ulhaq, Gita Vita Soraya and Fitri Arkham Fauziah
Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang, Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar and The Ministry of National Development Planning

Abstract:

Loading...

COVID-19, recurrent positive SARS-CoV-2 RNA tests, recovered patients, diagnostic

5.

Interleukin-6 Levels of Children Developing SARS-CoV-2 Infection

Pediatrics and Neonatology DOI/10.1016/j.pedneo.2020.04.007, Forthcoming
Posted: 16 Apr 2020 Last Revised: 13 May 2020
Gita Vita Soraya and Zulvikar Syambani Ulhaq
Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar and Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang

Abstract:

Loading...

IL-6, Interleukin, SARS-CoV-2, COVID-19, paediatric, cytokine storm

6.

Crucial Laboratory Parameters in COVID-19 Diagnosis and Prognosis: An Updated Meta-Analysis

Posted: 16 Apr 2020
Gita Vita Soraya and Zulvikar Syambani Ulhaq
Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar and Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang

Abstract:

Loading...

laboratory parameters, COVID-19, SARS-CoV-2, diagnosis

7.

Interleukin-6 as a Potential Biomarker of COVID-19 Progression

Médecine et Maladies Infectieuses, DOI: 10.1016/j.medmal.2020.04.002
Posted: 30 Mar 2020 Last Revised: 07 Apr 2020
Zulvikar Syambani Ulhaq and Gita Vita Soraya
Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universitas Islam Negeri Maulana Malik Ibrahim, Malang and Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar

Abstract:

Loading...

SARS-CoV-2, COVID-19, Novel Coronavirus, IL-6, prognosis